Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

86 PROCARE – phase 2 KCE reports 81Quality indicator Subdiscipline(s) Source Ex/inclusion Level Final QI(s)IF a patient is undergoing rectal cancer surgery and preoperative workupsuggests stage IV disease, THEN in addition to the surgeon the patientshould be evaluated preoperatively by:(a) medical oncologist(b) radiation oncologist(c) multidisciplinary tumour board(d) a and b, or cIF a patient is undergoing rectal cancer surgery and preoperative workupsuggests stage II–III disease, THEN in addition to the surgeon the patientshould be evaluated preoperatively by:(a) medical oncologist(b) radiation oncologist(c) multidisciplinary tumour board(d) a and b, or cIF a patient undergoes colorectal cancer surgery and
KCE Reports 81 PROCARE – phase 2 87Quality indicator Subdiscipline(s) Source Ex/inclusion Level Final QI(s)IF a patient is undergoing colorectal cancer surgery with neoadjuvanttherapy, THEN a CEA level should be obtained preoperatively:(a) before neoadjuvant therapyStaging McGory Inclusion 2 1213IF a patient is undergoing colorectal cancer surgery, THEN a total colonicexamination should be performed preoperatively between 12 mo beforeinitiation of treatment OR 12 mo after surgery OR document reason whynot performedIF a patient is undergoing rectal cancer surgery, THEN imaging of theabdomen/pelvis with CT or MRI should be performedIF a patient is undergoing rectal cancer surgery and receives neoadjuvanttherapy, THEN imaging of the abdomen/pelvis with CT or MRI should beperformed:(a) before neoadjuvant therapyIF a patient is undergoing rectal cancer surgery, THEN the depth oftumour invasion should be evaluated preoperatively or preneoadjuvanttherapy (if neoadjuvant given)IF a patient is undergoing rectal cancer surgery and CT does not showobvious wall invasion, THEN the depth of tumour invasion should beperformed preoperatively or preneoadjuvant therapy (if neoadjuvantgiven) by the following:(a) TRUS or EUS(b) MRI(d) a or b (but not c)IF a patient is undergoing rectal cancer surgery, THEN thecharacterization of perirectal lymph nodes should be performedpreoperatively or preneoadjuvant therapy (if neoadjuvant given)IF a patient is undergoing rectal cancer surgery, THEN thecharacterization of perirectal lymph nodes should be performedpreoperatively or preneoadjuvant therapy (if neoadjuvant given) by thefollowing:(a) TRUS or EUS(b) MRI(e) a or bIF a patient is diagnosed with colorectal cancer, THEN treatment shouldbe initiated within 10 weeks after biopsy or 6 weeks after seeing thesurgeon for consultation or documented why performed laterIF a patient undergoes rectal cancer surgery, THEN the distal marginshould be documented in the operative report and be:(a) at least 1 cmStaging McGory Inclusion 2 1214Staging McGory Inclusion 2 1215Staging McGory Inclusion 2 1215Staging McGory Inclusion 2 1215Staging McGory Inclusion 2 1215Staging McGory Inclusion 2 1215Staging McGory Inclusion 2 1215Staging McGory Inclusion 2 1217Surgery McGory Inclusion 2 1231
Page 1 and 2:
Assurance de qualitépour le cancer
Page 3 and 4:
Assurance de qualité pour lecancer
Page 5 and 6:
KCE Reports 81B Cancer rectal - pha
Page 7:
KCE Reports 81B Cancer rectal - pha
Page 10 and 11:
vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13:
2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15:
4 PROCARE - phase 2 KCE reports 811
Page 16 and 17:
6 PROCARE - phase 2 KCE reports 81F
Page 19 and 20:
KCE Reports 81 PROCARE - phase 2 92
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46: KCE Reports 81 PROCARE - phase 2 35
Page 87 and 88: KCE Reports 81 PROCARE - Phase 2 77
Page 95: KCE Reports 81 PROCARE - phase 2 85
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169:
Page 172 and 173:
Dépôt légal : D/2008/10.273/39
Page 174 and 175:
35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?